Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geriatric Hematology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04999085
What this trial is testing

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaDisability Physical+1 more
UNC Lineberger Comprehensive Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Testing effectiveness (Phase 2)Study completedNCT00003673
What this trial is testing

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Who this might be right for
Leukemia
Pfizer 55
Early research (Phase 1)UnknownNCT00636922
What this trial is testing

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Bayside Health 40
Not applicableLooking for participantsNCT06373471
What this trial is testing

Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment

Who this might be right for
Hematologic MalignancyTreatment AdherenceTreatment Complication+2 more
Odense University Hospital 152
Large-scale testing (Phase 3)Study completedNCT00232934
What this trial is testing

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

Who this might be right for
Multiple Myeloma
Gruppo Italiano per lo Studio del Mieloma Multiplo 400
Testing effectiveness (Phase 2)Looking for participantsNCT05025098
What this trial is testing

Precision Therapy Versus Standard Therapy in AML and MDS in Elderly

Who this might be right for
AML, AdultMDS
University Hospital, Akershus 36
Testing effectiveness (Phase 2)Ended earlyNCT00655395
What this trial is testing

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Viron Therapeutics Inc 25
Not applicableLooking for participantsNCT07309848
What this trial is testing

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

Who this might be right for
Blood TransfusionHip Fracture SurgeriesGeriatric+6 more
St. Antonius Hospital 374
Not applicableEnded earlyNCT02063113
What this trial is testing

Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.

Who this might be right for
Multiple Myeloma in Older Patients
Nantes University Hospital 48
Post-approval studies (Phase 4)Study completedNCT00277160
What this trial is testing

Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Who this might be right for
NeutropeniaBreast CancerLung Cancer+2 more
Amgen 852
Not applicableStudy completedNCT01619254
What this trial is testing

Impact of Hand Hygiene Activities on the Prevention of Intestinal Parasitic Infections and Anaemia Among School Children

Who this might be right for
Intestinal Parasitic InfectionsAnaemia
Mekelle University 365
Large-scale testing (Phase 3)Ended earlyNCT04817761
What this trial is testing

SPARK-ALL: Calaspargase Pegol in Adults With ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Institut de Recherches Internationales Servier 42
Large-scale testing (Phase 3)Study completedNCT00002719
What this trial is testing

Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaNeutropenia
European Organisation for Research and Treatment of Cancer - EORTC 500
Not applicableUnknownNCT01930916
What this trial is testing

Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients

Who this might be right for
Blood Coagulation DisordersBlood Coagulation Disorder With Prolonged Bleeding TimeBlood Coagulation Disorder With Prolonged Coagulation Time
University Hospital, Caen 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770698
What this trial is testing

Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic Leukemia+9 more
BeOne Medicines 30
Large-scale testing (Phase 3)Study completedNCT00927498
What this trial is testing

Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old

Who this might be right for
Acute Myeloid Leukemia
Acute Leukemia French Association 280
Not applicableActive Not RecruitingNCT04671693
What this trial is testing

A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

Who this might be right for
Late EffectsTesticular Germ Cell Tumor MixedNon-Metastatic Breast Carcinoma+6 more
Centre Leon Berard 500
Early research (Phase 1)Study completedNCT01379300
What this trial is testing

Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)

Who this might be right for
Thrombosis
Merck Sharp & Dohme LLC 42
Testing effectiveness (Phase 2)Study completedNCT01687387
What this trial is testing

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)

Who this might be right for
Acute Myeloid Leukemia
Innate Pharma 152
Next Page